TP53 and breast carcinoma: Zellars and co-workers demonstrated in 1530 mastectomy-treated breast cancer patients of whom 259 received adjuvant radiotherapy that P53 overexpression was independently associated with a significantly increased local failure rate in patients treated with mastectomy, with (RR 2.5, 95% CI 1.1–5.7) or without (RR 1.7, 95% CI 1.2–2.4) radiotherapy.